The effect of levosimendan on lung damage after myocardial ischemia reperfusion in rats in which experimental diabetes was induced

Journal of Surgical Research

Volumn 193, Issue 2, 2015, Pages 920-925

  Alkan, Metin ^a   Çelik, Ali ^a   Bilge, Mustafa ^a   Kiraz, Hasan Ali ^b   Kip, Gülay ^c   Özer, Abdullah ^a   Şivgin, Volkan ^a   Erdem, Özlem ^a   Arslan, Mustafa ^a   Kavutçu, Mustafa ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

Author keywords

Antioxidant system; Diabetes mellitus; Distant organ damage; Ischemia reperfusion; Levosimendan; Rat

Indexed keywords

CATALASE; GLUTATHIONE TRANSFERASE; LEVOSIMENDAN; MALONALDEHYDE; STREPTOZOCIN; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; LEFT CORONARY ARTERY; LIPID PEROXIDATION; LUNG ALVEOLUS WALL; LUNG INJURY; LUNG PARENCHYMA; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; RAT; REPERFUSION INJURY; SINGLE DRUG DOSE; STREPTOZOTOCIN-INDUCED DIABETIC NEUROPATHY; THORACOTOMY; WISTAR ALBINO GLAXO RAT; ANIMAL; COMPLICATION; DRUG SCREENING; EXPERIMENTAL DIABETES MELLITUS; RANDOMIZATION; WISTAR RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DRUG EVALUATION, PRECLINICAL; HYDRAZONES; LUNG INJURY; MALE; MYOCARDIAL REPERFUSION INJURY; PYRIDAZINES; RANDOM ALLOCATION; RATS, WISTAR; VASODILATOR AGENTS;

EID: 84917730330     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.08.038     Document Type: Article

References (30)

1. D.J. Hearse Reperfusion of the ischemic myocardium J Mol Cell Cardiol 9 1977 605
2. S.W. Werns, M.J. Shea, and B.R. Lucchesi Free radicals and myocardial injury: pharmacologic implications Circulation 74 1986 1
3. J.A. Thompson, and M.L. Hess The oxygen free radical system: a fundamental mechanism in the production of myocardial necrosis Prog Cardiovasc Dis 28 1986 449
4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. The diabetes control and complications trial research group N Engl J Med 329 1993 977
5. A. Likidlilid, N. Patchanans, T. Peerapatdit, and C. Sriratanasathavorn Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients J Med Assoc Thai 93 2010 682
6. G. Önem, M. Saçar, and H. Aybek Protective effects of cilostazol and levosimendan on lung injury induced by lower limb ischemia-reperfusion Turk J Thorac Cardiovasc Surg 20 2012 577
7. J.F. Murray, M.A. Matthay, J.M. Luce, and M.R. Flick An expanded definition of the adult respiratory distress syndrome Am Rev Respir Dis 138 1988 720
8. S. Antila, S. Sundberg, and L.A. Lehtonen Clinical pharmacology of levosimendan Clin Pharmacokinet 46 2007 535
9. J. García-Septien, J.A. Lorente, and M.A. Delgado Levosimendan increases portal blood flow and attenuates intestinal intramucosal acidosis in experimental septic shock Shock 34 2010 275
10. Z.Q. Hou, Z.X. Sun, and C.Y. Su Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction Cardiovasc Ther 31 2013 108
11. M. Ji, R. Li, and G.M. Li Effects of combined levosimendan and vasopressin on pulmonary function in porcine septic shock Inflammation 35 2012 871
12. M. Arslan, F.M. Comu, B. Isik, L. Oztürk, and E. Kesimci Effect of dexmedetomidine on erythrocyte deformability during ischemia-reperfusion injury of liver in diabetic rats Bratisl Med J 113 2012 687
13. H. Kocoglu, K. Karaaslan, E. Gonca, O. Bozdogan, and N. Gulcu Preconditioning effects of dexmedetomidine on myocardial ischemia/reperfusion injury in rats Curr Ther Res Clin Exp 69 2008 150
14. M.B. Yuksel, S. Kavak, and I. Gecit Short-term levosimendan treatment protects rat testes against oxidative stress Braz J Med Biol Res 45 2012 716
15. C.K. Peng, K.L. Huang, and C.P. Wu Glutamine protects ischemia-reperfusion induced acute lung injury in isolated rat lungs Pulm Pharmacol Ther 24 2011 153
16. O. Lowry, N. Rosenbraugh, L. Farr, and R. Randall Protein measurement with folin phenol reagent J Biol Chem 182 1951 265
17. T.M. Van Ye, A.M. Roza, G.M. Pieper, J. Henderson Jr., C.P. Johnson, and M.B. Adams Inhibition of intestinal lipid peroxidation does not minimize morphological damage J Surg Res 55 1993 553
18. H. Aebi Catalase in vitro Methods Enzymol 105 1984 121
19. W.H. Habig, M.J. Pabst, and W.B. Jakoby Glutathione S-transferases. The first enzymatic step in mercapturic acid formation J Biol Chem 249 1974 7130
20. I. Francischetti, J.B. Moreno, M. Scholz, and W.B. Yoshida Leukocytes and the inflammatory response in ischemia-reperfusion injury Rev Bras Cir Cardiovasc 25 2010 575
21. G. Steiner How can we improve the management of vascular risk in type 2 diabetes: insights from FIELD Cardiovasc Drugs Ther 23 2009 403
22. N. Tapuria, S.P. Junnarkar, and N. Dutt Effect of remote ischemic preconditioning on hepatic microcirculation and function in a rat model of hepatic ischemia reperfusion injury HPB (Oxford) 11 2009 108
23. H. Ito No-reflow phenomenon and prognosis in patients with acute myocardial infarction Nat Clin Pract Cardiovasc Med 3 2006 499
24. A. Morelli, A. Donati, and C. Ertmer Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study Crit Care 14 2010 R232
25. A. Trikas, C. Antoniades, and G. Latsios Long-term effects of levosimendan infusion on inflammatory processes and sFas in patients with severe heart failure Eur J Heart Fail 8 2006 804
26. A. Baltalarli, V. Ozcan, and F. Bir Ascorbic acid (vitamin C) and iloprost attenuate the lung injury caused by ischemia/reperfusion of the lower extremities of rats Ann Vasc Surg 20 2006 49
27. H. Yasa, N. Yakut, and B. Emrecan Protective effects of levosimendan and iloprost on lung injury induced by limb ischemia-reperfusion: a rabbit model J Surg Res 147 2008 138
28. H. Basel, S. Kavak, H. Demir, I. Meral, H. Ekim, and H. Bektas Effect of levosimendan injection on oxidative stress of rat myocardium Toxicol Ind Health 29 2013 435
29. J.P. Vázquez-Medina, T. Zenteno-Savín, and R. Elsner Antioxidant enzymes in ringed seal tissues: potential protection against dive-associated ischemia/reperfusion Comp Biochem Physiol C Toxicol Pharmacol 142 2006 198
30. E. Karakus, Z. Halici, and A. Albayrak Beneficial pharmacological effects of levosimendan on antioxidant status of acute inflammation induced in paw of rat: involvement in inflammatory mediators Basic Clin Pharmacol Toxicol 112 2013 156